Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: Implications for differential treatment efficacy

被引:59
|
作者
Outhred, Tim [1 ,2 ]
Hawkshead, Brittany E. [3 ]
Wager, Tor D. [4 ]
Das, Pritha [1 ,5 ,6 ]
Malhi, Gin S. [1 ,5 ,6 ]
Kemp, Andrew H. [1 ,2 ,5 ,6 ,7 ]
机构
[1] Univ Sydney, Royal N Shore Hosp, Sydney Med Sch, Discipline Psychiat, St Leonards, NSW 2065, Australia
[2] Univ Sydney, Sch Psychol, SCAN Res & Teaching Unit, Sydney, NSW 2006, Australia
[3] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA
[4] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA
[5] Royal N Shore Hosp, Dept Psychiat, CADE Clin, St Leonards, NSW 2065, Australia
[6] Univ Sydney, Royal N Shore Hosp, St Leonards, NSW 2065, Australia
[7] Univ Sao Paulo, Univ Hosp, BR-05508000 Sao Paulo, Brazil
来源
关键词
Antidepressants; SSRI; NRI; Serotonin; Noradrenalin; Emotion; fMRI; Multi-Level Kernel Density Analysis Meta-analysis; COGNITIVE NEUROPSYCHOLOGICAL MODEL; ANTERIOR CINGULATE CORTEX; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; INCREASED AMYGDALA; PREFRONTAL CORTEX; FACIAL EXPRESSIONS; NEURONAL RESPONSES; ANXIETY DISORDER; METAANALYSIS;
D O I
10.1016/j.neubiorev.2013.07.010
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Clinical research has demonstrated differential efficacy of selective serotonin reuptake inhibitors (SSRIs) and norepinephrine reuptake inhibitors (NRIs), which may relate to differential acute effects these medications have on emotional brain processes. Here we present findings from a Multi-Level Kernel Density Analysis meta-analysis that integrates and contrasts activations from disparate fMRI studies in order to examine whether single dose SSRIs and NRIs have different effects on emotion processing tasks in healthy participants. Seven SSRI and four NRI studies were eligible for inclusion. SSRIs decreased amygdala responses, suggesting reduced emotional reactivity to emotional stimuli, whereas NRIs increased frontal and medial activation, suggesting increased emotion regulation. As hypothesised, an interaction of antidepressant and task type was found, such that SSRIs modulated amygdaloid-hippocampal, medial and frontal activity during both the presentation of faces and pictures, whereas NRIs only modulated the activation in medial and frontal regions during the presentation of pictures. Findings are interpreted within a novel model of the differential effects of SSRIs and NRIs on emotion processing. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1786 / 1800
页数:15
相关论文
共 50 条
  • [41] The pharmacogenomics of selective serotonin reuptake inhibitors
    A Serretti
    P Artioli
    The Pharmacogenomics Journal, 2004, 4 : 233 - 244
  • [42] Pharmacokinetics of selective serotonin reuptake inhibitors
    Hiemke, C
    Härtter, S
    PHARMACOLOGY & THERAPEUTICS, 2000, 85 (01) : 11 - 28
  • [43] The pharmacogenomics of selective serotonin reuptake inhibitors
    Garcia-Marin, Luis M.
    Rabinowitz, Jill A.
    Ceja, Zuriel
    Alcauter, Sarael
    Medina-Rivera, Alejandra
    Renteria, Miguel E.
    PHARMACOGENOMICS, 2022, 23 (10) : 597 - 607
  • [44] Safety of selective serotonin reuptake inhibitors
    Jiménez, LG
    Salzman, G
    Golberg, P
    MEDICINA CLINICA, 2005, 124 (18): : 719 - 719
  • [45] Selective Serotonin Reuptake Inhibitors and Autism
    Walch, Tina J.
    Tinkelman, Amanda
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (02) : E325 - E325
  • [46] SELECTIVE SEROTONIN REUPTAKE INHIBITORS - REPLY
    FREEMANTLE, N
    SHELDON, TA
    SONG, FJ
    MASON, J
    HOUSE, A
    BRITISH MEDICAL JOURNAL, 1994, 309 (6961): : 1085 - 1085
  • [47] Selective serotonin reuptake inhibitors and SIADH
    不详
    MEDICAL JOURNAL OF AUSTRALIA, 1996, 164 (09) : 562 - 562
  • [48] Analysis of the Effects of Selective Serotonin (and Noradrenaline) Reuptake Inhibitors on the Risk of Dementia in Patients with Depression
    Kostev, Karel
    Bohlken, Jens
    Jacob, Louis
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 69 (02) : 577 - 583
  • [49] The genetics of selective serotonin reuptake inhibitors
    Kroeze, Yvet
    Zhou, Huiqing
    Homberg, Judith R.
    PHARMACOLOGY & THERAPEUTICS, 2012, 136 (03) : 375 - 400
  • [50] Selective serotonin reuptake inhibitors and acne
    Daveluy, Amelie
    de Bazignan, Adelaiede Doussait
    Thiessard, Frantz
    Miremont-Salame, Ghada
    Moore, Nicholas
    Haramburu, Francoise
    THERAPIE, 2006, 61 (01): : 71 - 72